Finance

Lists
AZTA:NASDAQ
Azenta, Inc
$33.33
+4.03%
(+1.29) 1D
$33.33
0.00% (0.00)
After hours
Closed: Aug 10, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AZTA...
Open
$31.77
High
$33.54
Low
$31.77
Mkt. cap
1.46B
Avg. vol.
676.62K
Volume
866.93K
52-wk high
$41.73
52-wk low
$15.93
EPS
-$3.87
Beta
1.37
Shares outstanding
43.81M
No. of employees
3K
Open
$31.77
High
$33.54
Low
$31.77
Mkt. cap
1.46B
Avg. vol.
676.62K
Volume
866.93K
52-wk high
$41.73
52-wk low
$15.93
EPS
-$3.87
Beta
1.37
Shares outstanding
43.81M
No. of employees
3K
News stories
From web sources and news partners
Profile
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics. Wikipedia
About Azenta, Inc
CEOJohn Marotta
Employees2.9K
Founded1978
HeadquartersBurlington, Massachusetts, United States
SectorHealth care
Websiteazenta.com
Analyst ratings
Based on 3 analysts giving stock ratings to AZTA in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AZTA in the last 3 months.
Highest
Current $33.33
$37.00 (+11.01%)
Average
$35.00 (+5.01%)
Lowest
$33.00 (-0.99%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vijay Kumar
Evercore ISI
Buy
Maintained
$35.00
+5%
08/06/2026
Brendan Smith
TD Cowen
Hold
Maintained
$33.00
-1%
08/05/2026
David Saxon
Needham
Buy
Reiterated
$37.00
+11%
08/05/2026
Matthew Stanton, CFA
Jefferies
Buy
Maintained
$35.00
+5%
04/01/2026
Last report
Aug 5, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
$0.16 / $0.10
+60.00%beat
Revenue / Est. (USD)
161.18M / 149.23M
+8.00%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
158.95M
148.64M
144.80M
161.18M
Cost of goods sold
90.99M
84.94M
82.76M
88.82M
Cost of revenue
90.99M
84.94M
82.76M
88.82M
Research and development expenses
10.46M
9.19M
9.43M
8.85M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55.73M
60.61M
67.89M
67.17M
Operating expense
66.18M
69.80M
77.32M
76.02M
Total operating expenses
157.17M
154.74M
160.08M
164.84M
Operating income
1.78M
-6.09M
-15.28M
-3.66M
Other non operating income
2.18M
979.00K
801.00K
1.30M
EBT including unusual items
5.78M
-2.06M
-157.34M
846.00K
EBT excluding unusual items
8.28M
-917.00K
-10.70M
1.36M
Income tax expense
-45.61M
3.13M
-323.00K
2.38M
Effective tax rate
-789.61%
-151.94%
0.21%
280.73%
Other operating expenses
-
-
-
-
Net income
50.84M
-15.43M
-160.80M
2.46M
Net profit margin
31.98%
-10.38%
-111.05%
1.52%
Earnings per share
0.21
0.09
-0.04
0.16
Interest and investment income
5.02M
5.10M
4.39M
3.82M
Interest expense
-
-
-
-
Net interest expenses
5.02M
5.10M
4.39M
3.82M
Depreciation and amortization charges
-
-
-
-
EBITDA
16.29M
7.55M
-1.28M
9.92M
Gain or loss from assets sale
93.07M
9.65M
6.33M
-5.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps